4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders

Details for Australian Patent Application No. 2002305994 (hide)

Owner AstraZeneca AB

Inventors Hudzik, Thomas; Walpole, Christopher; Brown, William; Plobeck, Niklas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002305994

PCT Number PCT/SE02/00956

PCT Pub. Number WO2002/094794

Priority 0103820-7 15.11.01 SE; 0101772-2 18.05.01 SE

Filing date 16 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 26 June 2008

International Classifications

C07D 295/14 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 233/24 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/94 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 295/155 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/52 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/66 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 0103820-7 15.11.01 SE; 0101772-2 18.05.01 SE

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002305994

15 May 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Hudzik, Thomas; Walpole, Christopher; Brown, William and Plobeck, Niklas

26 June 2008 Application Accepted

  Published as AU-B-2002305994

23 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305995-4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders

2002305993-4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders